A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction

[1] Gnecchi M(2008)Paracrine mechanisms in adult stem cell signaling and therapy Circ Res 103 1204-1219

[2] Zhang Z(2004)Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms Circulation 109 1543-1549

[3] Ni A(2007)Optimizing adult mesenchymal stem cells for heart repair J Mol Cell Cardiol 42 283-284

[4] Dzau VJ(2006)Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 1287-1294

[5] Kinnaird T(2002)Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 93-98

[6] Stabile E(2002)Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Ann Thorac Surg 73 1919-1925

[7] Burnett MS(2009)Allogenic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiation capacity Proc Natl Acad Sci USA 106 14022-14027

[8] Shou M(2011)Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells Stem Cell Res Ther 2 31-368

[9] Lee CW(2005)Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells Nat Med 11 367-734

[10] Barr S(2010)Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction J Am Coll Cardiol 56 721-135

[1] Gnecchi M(2008)Paracrine mechanisms in adult stem cell signaling and therapy Circ Res 103 1204-1219

[2] Zhang Z(2004)Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms Circulation 109 1543-1549

[3] Ni A(2007)Optimizing adult mesenchymal stem cells for heart repair J Mol Cell Cardiol 42 283-284

[4] Dzau VJ(2006)Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial Circulation 113 1287-1294

[5] Kinnaird T(2002)Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart Circulation 105 93-98

[6] Stabile E(2002)Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Ann Thorac Surg 73 1919-1925

[7] Burnett MS(2009)Allogenic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiation capacity Proc Natl Acad Sci USA 106 14022-14027

[8] Shou M(2011)Terminal differentiation is not a major determinant for the success of stem cell therapy - cross-talk between muscle-derived stem cells and host cells Stem Cell Res Ther 2 31-368

[9] Lee CW(2005)Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells Nat Med 11 367-734

[10] Barr S(2010)Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction J Am Coll Cardiol 56 721-135